Metagenics, headquartered in San Clemente, Calif., is a global life sciences company focused on reversing chronic illness and improving health by helping people achieve their genetic potential through nutrition. Founded in 1983, the company serves tens of thousands of health-care professionals and more than a million patients throughout the world and holds more than 40 proprietary formula patents for use in nutraceuticals – medical foods – and pharmaceuticals. Today, Metagenics continues its leadership role by successfully merging the disciplines of nutritional genomics, functional medicine and lifestyle medicine programs to find solutions to society's most pressing health concerns.

Alticor Corporate Enterprises assumed an ownership stake in Metagenics in 2009. Metagenics operates as a stand-alone company within the Alticor family of businesses and maintains its own management and distribution methods.

As the single largest practitioner brand in the U.S., Metagenics specializes in science-based products that address chronic illness and health concerns, including body composition and its effects upon blood sugar metabolism and heart health, gastrointestinal health, hormone balance, metabolic detoxification programs, and neurological health for women, men, and children. Metagenics delivers programs and products through more than 100,000 licensed health care professionals and pharmacies in North and South America, Australia, New Zealand, and Europe.

Alticor and Metagenics share a philosophy for promoting good nutrition, healthy living, and natural science. Through its Amway distribution channel and product lines like NUTRILITE®, Alticor and Metagenics offer complementary nutrition and wellness brands.  

Learn more at metagenics.com 


Products sold through Practitioners include:

 Bariatric Advantage    
   UnltrInflamX  
     
     


Products sold directly to consumers include:

 Ethical Nutrients  MetaRelax  Probactiol
 MenoHop  MetaStudent 3  


Board of Directors

Fred Howard
Chief Executive Officer - Metagenics, Inc.

James M. Weaver
Vice President, Managing Director – Alticor Corporate Enterprises

Roger C. Colman
Vice President, Acquisitions – Alticor Corporate Enterprises

David J. Tuit
Director, Finance & Operations – Alticor Corporate Enterprises

Jeffrey J. Katke
Chairman – Metagenics, Inc.

Jeff Bland, Ph.D., FACN, CNS
Chief Science Officer – Metagenics, Inc.
President – MetaProteomics

William (Bill) H. Baer, II, M.D., Pharm.D.
Executive Director/Chief Medical Officer of ClinXus

Richard Zahn
Corporate Governance and Public Policy – HMJ Global Partners